Bullboard - Stock Discussion Forum Gain Therapeutics Inc GANX

Healthcare Biotechnology

Gain Therapeutics, Inc. is a biotechnology company. The Company is focused on developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company’s drug... see more

Add To Watchlist

NDAQ:GANX - Post Discussion

Gain Therapeutics Inc > Gain Therapeutics Presents Data at the AD/PD(TM) 2024 Confer

View:

Post by whytestocks on Mar 05, 2024 10:00pm

Gain Therapeutics Presents Data at the AD/PD(TM) 2024 Confer

News; $GANX Gain Therapeutics Presents Data at the AD/PD(TM) 2024 Conference Demonstrating the Mechanism of Action of GT-02287, its Clinical Stage GCase Regulator for the Treatment of Parkinson's DiseaseBETHESDA, Md., March 05, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announ...GANX - Gain Therapeutics Presents Data at the AD/PD(TM) 2024 Conference Demonstrating the Mechanism of Action of GT-02287, its Clinical Stage GCase Regulator for the Treatment of Parkinson's Disease